Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating how different amounts of dietary fat influence the pharmacokinetics of oral testosterone undecanoate in men with hypogonadism; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Clarus Therapeutics, Inc. | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2018-04-12